Health Canada inspection
Taro Pharmaceuticals Inc: Health Canada inspection of Aug 24, 2020
Health Canada · GVP · rating C
Key facts
| Establishment | Taro Pharmaceuticals Inc |
|---|---|
| City | Brampton |
| Province | Ontario |
| Country | Canada |
| Program | GVP |
| Start date | Aug 13, 2020 |
| End date | Aug 24, 2020 |
| Rating | C |
| Rating description | Compliant |
| Licence number | 100232 |
At a glance
- 1–9 Observations cited
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.
Source: Health Canada, Drug and Health Product Inspections. Contains information licensed under the Open Government Licence – Canada · Source date: